Podlesak Dennis
Insider CIK 1314595 · ADYX Director · RGDO Director · SNDX Director · AVNR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2026-10-29 | 2026-10-30 | 8,000 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2026-10-29 | 2026-10-30 | 8,000 | $14.21 | $113.7K | 239,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2026-10-29 | 2026-10-30 | 8,000 | $11.81 | $94.5K | 247,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2026-02-04 | 2026-02-06 | 48,000 | — | $0 | 239,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2025-08-18 | 2025-08-18 | 19,200 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2025-08-18 | 2025-08-18 | 19,200 | $7.20 | $138.2K | 210,963 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2025-08-18 | 2025-08-18 | 19,200 | $15.84 | $304.1K | 191,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2025-08-15 | 2025-08-18 | 4,800 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2025-08-15 | 2025-08-18 | 14,400 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2025-08-15 | 2025-08-18 | 19,200 | $7.20 | $138.2K | 210,963 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2025-08-15 | 2025-08-18 | 19,200 | $15.54 | $298.4K | 191,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2025-08-14 | 2025-08-18 | 19,200 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2025-08-14 | 2025-08-18 | 19,200 | $7.20 | $138.2K | 210,963 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2025-08-14 | 2025-08-18 | 19,200 | $14.19 | $272.4K | 191,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2025-02-05 | 2025-02-07 | 50,000 | — | $0 | 191,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2024-02-07 | 2024-02-09 | 34,000 | — | $0 | 141,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2023-02-02 | 2023-02-03 | 32,000 | — | $0 | 107,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2022-09-16 | 2022-09-16 | 5,419 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2022-09-16 | 2022-09-16 | 6,556 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2022-09-16 | 2022-09-16 | 5,419 | $6.32 | $34.2K | 81,182 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2022-09-16 | 2022-09-16 | 6,556 | $23.43 | $153.6K | 75,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2022-09-16 | 2022-09-16 | 6,556 | $6.35 | $41.6K | 82,319 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2022-09-16 | 2022-09-16 | 5,419 | $23.43 | $127.0K | 75,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2022-09-15 | 2022-09-16 | 66,840 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2022-09-15 | 2022-09-16 | 66,840 | $24.20 | $1.62M | 75,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2022-09-15 | 2022-09-16 | 66,840 | $6.32 | $422.4K | 142,603 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2022-02-02 | 2022-02-03 | 32,000 | — | $0 | 75,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | J Other | 2021-10-05 | 2021-10-06 | 463 | — | $0 | 43,763 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | P Buy | 2021-04-22 | 2021-04-22 | 13,967 | $14.11 | $197.1K | 43,300 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2021-02-03 | 2021-02-05 | 29,333 | — | $0 | 29,333 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2020-02-12 | 2020-02-14 | 44,000 | — | $0 | 44,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2019-06-10 | 2019-06-12 | 44,000 | — | $0 | 44,000 | SEC↗ |
| ADYX Alliqua BioMedical, Inc. | A Award deriv | 2019-05-03 | 2019-05-07 | 396 | — | $0 | 396 | SEC↗ |
| ADYX Alliqua BioMedical, Inc. | A Award deriv | 2019-05-03 | 2019-05-07 | 55,879 | — | $0 | 55,879 | SEC↗ |
| ADYX Alliqua BioMedical, Inc. | A Award | 2019-05-03 | 2019-05-07 | 85,254 | — | $0 | 85,254 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2018-05-23 | 2018-05-25 | 14,000 | — | $0 | 14,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2018-02-08 | 2018-02-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2017-05-17 | 2017-05-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2017-05-17 | 2017-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 40,733 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 2,947 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 53,334 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 27,500 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 1,071 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 17,695 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 10,253 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 232 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 9,314 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 232 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2016-10-31 | 2016-11-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2016-01-12 | 2016-01-14 | 53,334 | — | $0 | 53,334 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2015-07-09 | 2015-07-13 | 27,500 | — | $0 | 27,500 | SEC↗ |
| RGDO Regado Biosciences Inc | A Award deriv | 2015-01-01 | 2015-01-05 | 159,261 | — | $0 | 159,261 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2014-02-12 | 2014-02-14 | 28,900 | — | $0 | 336,394 | SEC↗ |
| RGDO Regado Biosciences Inc | A Award deriv | 2014-01-01 | 2014-01-03 | 9,640 | — | $0 | 9,640 | SEC↗ |
| RGDO Regado Biosciences Inc | A Award deriv | 2013-08-27 | 2013-08-29 | 366,605 | — | $0 | 366,605 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2013-02-14 | 2013-02-19 | 38,900 | — | $0 | 307,494 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2012-02-16 | 2012-02-17 | 30,000 | — | $0 | 268,594 | SEC↗ |